Wilbert T. Zwart

Robinson Way
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 167 publications

Germline CDK12 variants in aggressive prostate cancer.

Germline CDK12 variants in aggressive prostate cancer.

Journal: Cancer discovery

Published: January 14, 2026

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

Journal: Cancer discovery

Published: December 16, 2025

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 04, 2025

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

DEprot: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data.

Journal: NAR genomics and bioinformatics

Published: November 05, 2025

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer.

p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 29, 2025

DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

Journal: Blood

Published: September 10, 2025

Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer.

Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 15, 2025

Zincore, an atypical coregulator, binds zinc finger transcription factors to control gene expression.

Zincore, an atypical coregulator, binds zinc finger transcription factors to control gene expression.

Journal: Science (New York, N.Y.)

Published: July 03, 2025

IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

Journal: EMBO molecular medicine

Published: June 04, 2025

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

Journal: Oncogene

Published: May 18, 2025

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Journal: European urology oncology

Published: April 30, 2025

Showing 1-12 of 167

Last Updated: 09/26/2026